Vertex Pharmaceuticals Inc (VRTX): Shares Outstanding
253.99M
As of 2025-12-31
253.35M
As of 2026-06-30
-0.4%
3-year compound annual growth
-0.5%
5-year compound annual growth
+0.3%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 253.99M | -1.1% | 2026-02-13, Balance as of period end |
| 2024-12-31 | 256.94M | -0.3% | 2026-02-13, Balance as of period end |
| 2023-12-31 | 257.70M | +0.3% | 2025-02-13, Balance as of period end |
| 2022-12-31 | 257.01M | +1.0% | 2024-02-15, Balance as of period end |
| 2021-12-31 | 254.48M | -2.1% | 2023-02-10, Balance as of period end |
| 2020-12-31 | 259.89M | +0.3% | 2022-02-09, Balance as of period end |
| 2019-12-31 | 258.99M | +1.5% | 2021-02-11, Balance as of period end |
| 2018-12-31 | 255.17M | +0.8% | 2020-02-13, Balance as of period end |
| 2017-12-31 | 253.25M | +2.0% | 2019-02-13, Balance as of period end |
| 2016-12-31 | 248.30M | +0.8% | 2018-02-15, Balance as of period end |
| 2015-12-31 | 246.31M | +1.9% | 2017-02-23, Balance as of period end |
| 2014-12-31 | 241.76M | +3.4% | 2016-02-16, Balance as of period end |
| 2013-12-31 | 233.79M | +7.6% | 2015-02-13, Balance as of period end |
| 2012-12-31 | 217.29M | +3.8% | 2014-02-11, Balance as of period end |
| 2011-12-31 | 209.30M | +2.8% | 2013-03-01, Balance as of period end |
| 2010-12-31 | 203.52M | +1.8% | 2012-02-22, Balance as of period end |
| 2009-12-31 | 199.96M | n/a | 2011-02-17, Balance as of period end |